BioAtla, Inc. Reports on Shareholder Vote Matters

Ticker: BCAB · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1826892

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: BCAB

TL;DR

BioAtla filed an 8-K about a shareholder vote. Details TBD.

AI Summary

BioAtla, Inc. filed an 8-K on June 13, 2024, to report on the submission of matters to a vote of its security holders. The filing does not contain details about specific proposals or outcomes of any vote, but indicates that a shareholder vote-related event has occurred or is being reported.

Why It Matters

This filing signals that BioAtla, Inc. has engaged in or is reporting on a process involving shareholder decision-making, which can impact corporate governance and future strategic directions.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose immediate financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of BioAtla, Inc.'s security holders?

The filing does not specify the exact matters submitted for a vote, only that such matters were presented.

When did the event related to the submission of matters to a vote occur?

The earliest event reported is dated June 13, 2024.

What is the Commission File Number for BioAtla, Inc.?

The Commission File Number for BioAtla, Inc. is 001-39787.

Where is BioAtla, Inc. headquartered?

BioAtla, Inc.'s principal executive offices are located at 11085 Torreyana Road, San Diego, California, 92121.

What is the SIC code for BioAtla, Inc.?

The Standard Industrial Classification (SIC) code for BioAtla, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Stats: 591 words · 2 min read · ~2 pages · Grade level 14.5 · Accepted 2024-06-13 17:11:14

Key Financial Figures

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting of Stockholders of BioAtla, Inc. (the " Company ") was held online via live audio webcast on June 13, 2024 (the " Annual Meeting "). At the Annual Meeting, there were present, in person virtually or by proxy, holders of 34,513,932 shares of common stock, or approximately 71.75 % of the total outstanding shares eligible to be voted. The final voting results with respect to each proposal presented at the Annual Meeting is set forth below: Proposal One - Election of Directors The Company's stockholders approved the election of one Class I director to the Company's Board of Directors for a three-year term or until her successor is duly elected and qualified or until her earlier death, resignation, disqualification or removal, by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Sylvia McBrinn 15,280,856 7,634,075 11,599,001 Proposal Two - Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 by the following votes: Votes For Votes Against Abstentions 34,271,982 106,553 135,397 Proposal Three - Non-Binding Advisory Vote on the Executive Compensation of Our Named Executive Officers The Company's stockholders approved, on a non-binding advisory basis, the executive compensation of our named executive officers by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 17,643,438 5,121,016 153,387 11,596,091

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioAtla, Inc. Date: June 13, 2024 By: /s/ Richard A. Waldron Richard A. Waldron Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing